Stocks
Bristol-Myers (BMY) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 8.29 | 9.61 | 6.99 | 48.9 | 10.1 | 10.9 | ||
| Changes by years, y/y, % | -76% | +16% | -27% | +600% | -79% | -22.1% | |||
Bristol-Myers. EV/EBITDA
Bristol-Myers. EV/EBITDA, changes, %
Bristol-Myers (BMY) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 10.1 | 8.72 | 8.49 | 10.1 | 11.5 | 10.9 | |
| Changes by years, y/y, % | -66% | -66% | -71% | -79% | +14% | |||
| Changes by quarters, q/q, % | -79% | -14% | -3% | +19% | +14% | |||
